glp 1 in the brain GLP-1 Analogues Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives Study identifies new concepts for

Novo Nordisk, the Danish pharma company behind several GLP-1RA drugs (including Ozempic/Wegovy and Saxenda) grew its sales by over 30% in 2023, and its share price rose by over 70% in the last year, making it the most valuable European company by market capitalization

doi: 10.1093/chemse/bjac004

This combination of blood sugar stabilization and healthy weight management can be particularly useful for those with chronic conditions like diabetes, heart disease and obesity

Although GLP-1RA stimulate sympathetic outflow to adipose tissues in rodents [[68], [69], [70]], a consistent effect on energy expenditure has not been clearly established [78]